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ABSTRACT 
 
STUDIES ON SUPEROXIDE DISMUTASE INHIBITION AND APPLICATION OF 
METHODS TO STUDY METAL ION PARTICIPATION IN COMPLICATION OF DIABETES 
Benjamin Hickman 
Western Carolina University (May 2012) 
Director: Dr. Jack Summers 
 
 
Studies on Superoxide Dismutase Inhibition 
We used NMR relaxation rates to study reactions of the enzyme superoxide dismutase 
(SOD) with low molecular weight polyphenolic compounds. While the compounds appeared to 
inhibit SOD, we discovered evidence that the reaction proceeds with electron transfer from the 
polyphenols to the enzyme, giving a form of the SOD that was inactive in the assay but retained 
enzymatic activity.  The reaction was highly dependent on the aggregation and protonation states 
of the compounds.  
 
 
Application of Methods to Study Metal Ion Participation in Complication of Diabetes 
Diabetics display increases in chemical modification of proteins and also increased levels 
of oxidative stress. Alderson et al. reports one of these modifications involves reaction of the 
sulfhydryl group of cysteine residues with the Krebs Cycle intermediate fumarate. It has been 
proposed that the product, S-(2-Succinyl)cysteine (2SC), can bind metals, and may catalyze 
reactions such as the Haber-Weiss cycle. It is possible that 2SC will catalyze the 
disproportionation of superoxide. To study the possible link between 2SC and oxidative stress we 
synthesized two model compounds and studied their reactions. One of these is S-(2-succinyl)-N-
acetlycysteine (2SAC). We have shown the 2SAC will bind copper with a stability constant of 
log(K)= 3.59 ± 0.05. Also we have shown that the compound 2SAC-Cu will catalyze the Haber-
Weiss reaction but not the disproportination of superoxide. Furthermore, since glutathione 
concentrations in vivo can reach up to 10 mM it seems likely that reduced glutathione will react 
with fumerate to give S-(2-succinyl)-glutathione (2SGT). To study its possible role in vivo, we 
synthesized 2SGT. For the 2SGT compound, the binding constant of Cu-2SGT was determined to 
be log(K)=10.9 ± 0.2. Likewise, we have found that 2SGT binds to copper in such a way as to 
prevent catalysis of further reactions. Our attempts to study the iron complexes for these 
compounds have been unsuccessful due to their low solubility. 
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INTRODUCTION 
 
In this thesis two projects are discussed. The first is Studies on Superoxide Dismutase 
Inhibition and the second being Application of Methods to Study Metal Ion Participation in 
Complication of Diabetes. The background, experimental methods, and results and discussion are 
given for the Studies on Superoxide Dismutase Inhibition project, followed by the background, 
experimental methods, and results and discussion for the Application of Methods to Study Metal 
Ion Participation in Complication of Diabetes project.  
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STUDIES ON SUPEROXIDE DISMUTASE INHIBITION 
 
 
Studies on Superoxide Dismutase Inhibition Background 
During natural metabolism, some molecular oxygen is converted to the superoxide 
radical (O2
. -), leading to oxidative stress.2 This is done by the superoxide radical being converted 
to the hydroxyl radical (OH.) through the Haber-Weiss reaction (equation 1 and 2).1 Hydroxyl 
radical is a reactive oxygen species that may react with proteins or nucleic acids to alter or 
prevent their function, and may eventually lead to cell apoptosis.2,3  
  + .	 →  +  (1) 
  +  →  + 	 + . (2) 
 
The superoxide dismutase (SOD) enzymes catalyze the disproportionation of superoxide 
radicals. This neutralization occurs via a cyclic redox reaction of a metal in the SOD’s active site. 
When the superoxide radical contacts the metal it is converted into either molecular oxygen or 
hydrogen peroxide as described in equation 3 and 4.4 
  +.	 → 	 +  (3) 
 	 + .	 + 2 →  +  (4) 
     
 In this study we used bovine CuZn SOD enzyme which has copper and zinc as cofactors. 
In the CuZn SOD, it is the copper that cycles from its +2 and +1 oxidation states and participates 
in the redox reaction described above.  
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 Inhibiting the SOD would increase oxidative stress in a cell. For this reason, inhibitors of 
SOD are of interest as potential anti-cancer and anti-bacterial drugs. Cancer cells have an 
increased cell metabolism compared to normal cells, causing the oxidative stress to be high.5 This 
inherently high oxidative stress level should make cancer cells sensitive to SOD inhibition. 
Bacterial cells are thought to rely on SOD to survive oxidative burst by immune cells, for this 
purpose bacterial cells up regulate the production of SOD which should also make them sensitive 
to SOD inhibition.6,7  
Huang et al. showed in 2000 that the estrogen derivative 2-methoxyestradiol was able to 
inhibit SOD in leukemia cells.8 This inhibition was able to kill the leukemia cells while 
preserving the healthy cells; showing that inhibitors of SOD can be used to selectively target 
cancer cells.   
Traditionally, screening for SOD inhibitors involved the generation and detection of the 
highly reactive superoxide radical (O2
.).9 These assays produce the superoxide radical via 
enzymatic (xanthine oxidase) or non-enzymatic (Nicotinamide adenine dinucleotide (NADH)/ 
Phenazine methosulfate (PMS)) sources in a solution with the SOD and inhibitor(s).9 A detector 
molecule such as nitroblue tetrazolium (NBT) or ferricytochrome c is added and then reduced by 
the reactive superoxide radical. The extent to which the detector molecules are reduced can be 
measured via UV/Vis spectroscopy indicating how well the inhibitors were able to prevent the 
neutralization of these superoxide radicals by the SOD.9 It has been reported that these traditional 
methods give false positive results due to unwanted interactions between assay components.8,10 
These unwanted interactions can occur by either the intended SOD inhibitors inhibiting the 
superoxide source or they can themselves react with the superoxide radicals.8,10 
Vigilino et al.11 showed that the 19F NMR resonance of the fluoride ion (19F- ) was highly 
affected by the presence of small quantities of oxidized (Cu2+) form of SOD (as low as 10-7 M 
14 
 
SOD).11 This effect on the fluoride ion resonance results when the fluoride coordinates with 
paramagnetic copper in the SOD’s active site.  Since the superoxide radical also coordinates 
copper in the SOD’s active site in the disproportionation reaction, the fluoride ion makes a good 
probe to model the superoxide radical.12 By observing the fluoride NMR signal in the presence of 
SOD, it should be possible to determine whether access to SOD’s active site is blocked by an 
inhibitor. However, this assay will break down if the copper in the active site dos not remain in 
the paramagnetic form (Cu2+) since the diamagnetic form (Cu1+) does not affect the NMR assay.  
From the result of Huang et al. Dr. Summers’s group decided to look at phytoestrogens 
for anti-SOD activity. Previously our group looked at a number of phytoestrogens and found that 
some molecules from the class of flavonols showed apparent SOD inhibition.26 In this study we 
used 19F NMR to study apparent anti-SOD activity by a selection of flavonols. From apparent 
inhibition data we developed a structure-activity relationship (SAR) for the flavonols. 
Computational work was performed in an attempt to rationalize the SAR developed from the 
flavonol inhibition data.  From the SAR developed using the falvonols we found other small 
phenolic molecules that also displayed apparent anti-SOD behavior. However further studies on 
these compounds show that inhibition is not occurring. Rather, a redox reaction occurs between 
the polyphenols and the copper cofactor in the SOD.  
 
 
Superoxide Dismutase Inhibition Experimental 
 
Inhibition determined by 
19
F
-
 NMR. Apparent SOD inhibition was characterized by 
monitoring the effects of SOD on the 19F- NMR T2 relaxation rate of the fluoride ion. The assay 
15 
 
19F- Relaxation 
A)    B)       
Figure 1: A) A typical plot showing decay of the 
fluoride signal with time. B) The integrated decays 
exponentially with time. 
uses the Carr-Purcell- Meiboom- Gill (CPMG) NMR experiment to measure the transverse 
relaxation rate of the fluoride signal (R2), which is the inverse of the transverse relaxation time 
(T2) (Equation 5). The rate of relaxation for the fluoride ion is given by equation 6. Where I0 is 
the initial intensity of the fluoride signal and Iobs is the intensity of the fluoride signal after a 
relaxation delay time, t. By taking the natural log of both sides equation 7 is obtained. Using 
equation 7 the relaxation rate (R2) is equal to the slope, from lest squares regression, when the 
natural log of the fluoride signal intensity is plotted as a function of time (Figure 1a and 1b).  
 
When the fluoride contacts the paramagnetic copper it loses coherence with the rest of the 
fluoride ions. This loss of coherence causes the net fluoride signal to be smaller, giving faster 
relaxation rate (R2) compared to solutions without paramagnetic copper, or solutions in which 
access to the copper is blocked 
by an inhibitor.  
The fraction of SOD 
that retains NMR activity in an 
assay can be found using 
equations 8 and 9. Where R2 
observed is the relaxation of a 
sample with SOD and inhibitor, 
  = 1 
(5) 
  = 	 (6) 
 ln = ln − ! (7) 
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R2 neg. control is the relaxation of a sample with no inhibitor or SOD, and R2 pos. control is the relaxation 
of a sample with SOD but no inhibitor. (Originally, we thought the inactive SOD had an inhibitor 
bound to the active site. If this were the case, then dissociation constant for an inhibitor is given 
by equation 10.)  
 
 1 = [#$%&'()] + [#$'%&'()][#$%+]  
(8) 
 [#$%&'()] = 	)-(). − 	)/.&-+	0.&-+ − 	)/.&-+ 
(9) 
 1. = [#$%&'()][23	45ℎ474!83][#$'%&'()]  
(10) 
 9 11.: [45ℎ474!83] =
1
[#$%&'()] − 1 
(11) 
 
 Using equations 9 and 10 equation 11 can be obtained. From equation 11 a plot of 

[;<=>?@ABC] − 1 as a function of inhibitor concentration should be linear, with a slope of D EFG. It 
should be noted that for the flavonols, these plots typically show curvatures at higher 
concentrations. We attribute this curvature to aggregation of the inhibitor (discussed later). 
 
Superoxide dismutase. Bovine CuZn SOD was obtained from MP Biomedicals LLC and 
used without further purification. 
 
19
F
-
 NMR buffers. Buffers were chosen depending on the desired pH. Table 1 show a list 
of buffers used. Buffer solutions were made to contain 20mM buffer, 20mM sodium fluoride, and 
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10% by volume deuterium oxide in HPLC water. 
The buffers were adjusted with minimal amounts of 
1N NaOH or HCl to reach the desired pH. 
 
19
F
-
 NMR controls. 10 µL of DMSO and 
490 µL the buffer solution described above was taken for a negative control. To the remaining 
buffer SOD was added to obtain an R2 value between 50 and 100 S
-1 (approximately 2x10-8 M 
SOD was required per R2 value. The amount varied with pH and SOD batch). A 500 µL sample 
of buffer with SOD was taken for a positive control.  
 
19
F
-
 NMR inhibitor solutions. Inhibitor solutions containing 50 times the desired NMR 
sample concentration were made in DMSO. NMR samples were made by adding 10 µL of 
inhibitor solutions to 490 µL of the buffer solution containing SOD; which gives samples 
containing 2% DMSO and the desired inhibitor concentration. 
 
Computational studies. 
Enzyme structure energy minimization. From the Protein Data Bank, the 1PU0 CuZn 
SOD crystal structure was downloaded into MOE. The first monomer of the 5 dimer aggregate 
was isolated, and all the residual water molecules were deleted. The structure was then protonated 
to correspond to a pH of 8 using the protonate 3D application in MOE. The energy of the system 
was minimized while tethering heavy atoms with a restoring force of 500 in the energy minimize 
application of MOE. The partial charges of the atoms were calculated with the partial charge 
calculate application of MOE.  
pKa Buffer 
4.8 Acetate 
4.8 Citrate 
6.8 Pipes 
8.3 Tris 
9.6 Glycine 
10.7 Triethylamine 
Table 1: Buffers used and their pKas 
18 
 
 
Moe flavonol-SOD docking simulation. The flavonols (Table 4) were built in MOE, and 
put into a database (the flavonols were deprotonated at the 4’ position to correspond to a pH of 8). 
The structures of the flavonols were adjusted to minimize their energy using the energy minimize 
application.  
 The active site of the SOD was selected to be the residues within approximately 12 Å of 
the copper atom (this was done because the length of a flavonol is about 12 Å). The flavonols 
were then docked to the selected active site using the Triangle Matcher placement method. The 
docked poses were then energy minimized using the Force Field minimization option in MOE. 
The binding energies of the energy minimized poses were then scored using the London DG 
scoring method. Each of the poses was put into a database containing the 3D structures and the 
resulting binding scores.  
 
MOE SOD dynamics simulation. Starting from the energy minimized structure the MOE 
dynamics application was then used to simulate molecular movement for ten nanoseconds. 
During the simulation volume and temperature were held constant at 43557 Å and 300 K 
respectively.  A molecular file of the enzyme was collected every ten picosecond and stored in a 
database. 
 
MOE simulation of flavonol/SOD chelate interactions. Flavonols were fit into the active 
site of the energy minimized SOD so that the 3’ and 4’ hydroxyl groups could chelate to the 
copper atom. The 3’ and 4’ hydroxyls were then fixed so that they would not move during an 
19 
 
energy minimization. The energy of the system was then minimized, and the binding energy was 
noted.  
 
Flavonol fluorescence. Buffer solutions were prepared using 20 mM Tris in HPLC 
water, and adjusted to pH 8 using 1M NaOH. Flavonols were dissolved in a minimal amount of 
buffer, which varied with the solubility of the flavonols. A dilution using buffer was performed to 
obtain a 512 µM flavonol solution. Nine 1:2 serial dilutions of flavonols were performed starting 
at 512 µM and going down to 1 µM. Fluorescence spectra of the flavonol solutions were obtained 
using a Perkins Elmer LS 55 Luminescence Spectrometer.  
 
Principal component analysis of flavonol fluorescence data. Using Matlab2011a, the 
fluorescence data for each of the flavonols were loaded into a matrix. The matrix was arranged 
into n rows and m columns, where n is the number of spectra and m is the spectral intensity at 
each wavelength. The principal component analysis was done using a matlab code developed by 
Dr. S. Huffman of Western Carolina University (Appendix A).  
 
Gallic ester synthesis. Gallic acid and five pentyl alcohol isomers (3-methyl-2-butyl, 
neopentyl, isoamyl, 2-methyl-1-butyl, 1-pentyl, 3-pentyl alcohol) were obtained from Acros 
Organics and used without further purification. To a 10 mL tear drop flask, approximately 0.1 g 
of gallic acid was added. To this flask approximately 2 mL of the desired alcohol was added with 
a magnetic stir bar and gently stirred. An equal molar amount (relative to gallic acid) of 
concentrated sulfuric acid was added drop wise. A condenser was fitted to flask and the solution 
was heated until the gallic acid dissolved and refluxed for 2-3 hours. Upon reaction, the solution 
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changed from colorless to pale yellow for each ester. Approximately 90 percent of the excess 
alcohol was evaporated off using a rotovap. Solutions were not evaporated to dryness so as not to 
over-concentrate the sulfuric acid. The remaining solution was transferred into a separatory 
funnel using a minimal amount of ethyl acetate. Saturated sodium bicarbonate was added until the 
pH was neutral (pKa1 of the esters is about 8) and then separated from the organic layer. The 
organic layer was then washed 2 times with deionized water. Then the organic layer was 
transferred to a round bottom flask and the ethyl acetate was rotovaped off. The remaining crude 
product was evacuated overnight to remove residual alcohol starting material. Samples were 
characterized by 1H NMR (Table 2) 
 
 
 
Ester 1H NMR chemical shift (ppm) (DMSOd6), multiplicity, 
integration 
3-methyl-2-butyl 
gallate 
0.90 (d,6H), 1.20 (d, 3H), 1.80 (m,1H), 4.85 (m, 1H) 
Neopentyl Gallate 0.95 (s, 9H), 3.87 (S, 2H) 
Isoamyl gallate 0.90 (d, 6H), 1.55 (q, 2H), 1.75 (m, 1H), 4.20 (t, 2H) 
2-methyl-1-butyl 
gallate 
0.90 (m, 6H), 1.20 (m, 1H), 1.45 (m, 1H), 1.75 (m, 1H), 4.05 
(m, 2H) 
1-pentyl gallate 0.92 (t, 3H), 1.40 (m, 4H), 1.72 (m, 2H), 4.25 (t, 2H) 
3-pentyl gallate 0.85 (t, 6H), 1.60 (m, 4H), 4.79 (m, 1H) 
Table 2: Pentyl gallate esters 1H NMR data. 
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SOD metal sequestering.  To 2 mL glycine buffer (20 mM, pH 10) approximately 4400 
units of SOD were added. 1 mL of this buffer/SOD solution was put into an Eppondorf tube with 
16.2 µL of a 123 mM methyl 3,4-dihydroxybenzoate (MDHB figure 17) solution in DMSO. To 
the remaining 1 mL of buffer/SOD 16.2 µL of DMSO was added for a control. The control and 
MDHB solutions were allowed to equilibrate overnight at room temperature. After equilibration, 
500 µL of the MDHB and control solutions were filtered through an YM-10 membrane filtration 
device (10 KDa molecular weight cutoff) (Millipore).  The filtered and unfiltered MDHB and 
control solutions were each treated with 150 µL of concentrated HNO3, and dilute with 2.35 mL 
of HPLC H2O. Copper concentrations of each solution were found using a Perkins Elmer ICP-
OES Optima 4100 DV spectrometer. 
 
Enzyme concentration 
dependence of inhibition on quercetin. 
10 mL of a NMR buffer at pH 8 
(prepared as described above for 19F- 
NMR buffers), 1 mL of a 1.5 mM 
quercetin in DMSO solution, and a 
solution containing approximately 4400 
units of SOD dissolved in 200 µL of 
HPLC water were made. NMR samples 
were prepared containing between 44 and 
308 units of SOD (Table 3). Using the 
control samples (samples A-C), the 
predicted relaxation rates were extrapolated for the higher concentrations of SOD.   
Sample μL 
buffer 
μL quercetin in 
DMSO 
μL 
DMSO 
μL 
SOD 
A 588 0 12 2 
B 588 0 12 4 
C 588 0 12 8 
D 588 12 0 2 
E 588 12 0 4 
F 588 12 0 8 
G 588 12 0 10 
H 588 12 0 12 
I 588 12 0 14 
Table 3: Solution contents for the enzyme 
concentration dependence experiment. 
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SOD redox activity with superoxide and quercetin. A pH 8 NMR buffer was prepared 
as described above and SOD was added until the sample had an R2 value of approximately 100 s
-
1. Two aliquots of this buffer/SOD solution (500 µL) were taken and one was treated with 10 µL 
of a 1.5 mM quercetin solution in DMSO to give a final quercetin concentration of 30 µM. The 
other was used as a control. From concentrated stock solutions NADH and PMS were added to 
the two samples to give final concentrations of 78 and 3.3 μM respectively with a negligible 
effect on the total volume. The time after the NADH and PMS addition was monitored with a 
stopwatch. The 19F NMR relaxation rate (R2) was monitored using the CPMG experiment until it 
stabilized.  
 
 
Studies on Superoxide Dismutase Inhibition Results and Discussion 
 
Table 4 shows apparent inhibition data obtained from the 19F NMR assay for a selection 
of the flavonols.26 Due to the aggregation of the inhibitors it was not possible to accurately 
determine Kd for some of the inhibitors. However, IC50 values (concentration at which 50% of the 
SOD is inhibited) are also reported, which can be determined without quantifying the aggregation 
of the inhibitor (discussed later).  
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Flavonol 
IC50 
(μM) 
Kd 
(μM) 
Kdim-1 
(μM) 
Flavonol 
IC50 
(μM) 
Kd 
(μM) 
Kdim-1 
(μM) 
7
6
5
8
4
3
2
O
1
6 '
5 '
4 '2 '
3 '
O
Generic 
N/A N/A N/A 
 
3,6,3‘,4'TetHF 
140 10±5 2.0±1.5 
 
Myricetin 
6.7 6.8±1.6 24±6 
 
Fisetina 
69   
 
Quercetin 
12 12±4 30±15 
 
Luteolina,b 
>1000   
 
 
Gossypin 
39 13±5 15±6 
 
Apigeninb 
>1000 >200 59 
 
3,3‘,4'TriHFb 
820 19±5 7±3 
 
Morinb 
>1000 >200 330 
Table 4: Inhibition and dimerization data of selected flavonols at pH 8.  
a) Kdim could not be determined accurately from fluorescence data. 
b) IC50 estimated by extrapolation of reciprocal activity versus [inh]
0.5 plot. 
 
 
More recently we found evidence that inhibitors reduce the paramagnetic copper (II) to 
diamagnetic copper (I) rather than binding to the active site. This appears to be the mechanism by 
which the compounds inhibit NMR relaxation by the SOD enzyme (discussed later). 
 
Flavonols structure-activity relationship. We found that some flavonols inhibit SOD 
NMR relaxation while others similar compounds have no activity. All the active flavonols 
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(defined as one that has an apparent Kd less than 100 μM) had the 3’, 4’ and 3 position hydroxyl 
groups present (red hydroxyl groups in Table 4) while flavonols, without all of these groups, 
showed no activity.  
We originally suspected that the 3’ and 4’ hydroxyl groups participate in inhibition by 
chelating to the copper. More recent data suggest the 3’ and 4’ hydroxyl groups may be oxidized 
to the stable quinone moiety. Flavonols containing catechhol groups have lower oxidation 
potentials than flavonols lacking this group. This necessity of the 3’ and 4’ hydroxyl is illustrated 
by the comparing the activities of morin, apigenin, and quercetin. The structures of morin and 
quercetin differ in that the 3’ hydroxyl group in quercetin is shifted to the 5’ position in morin; 
this shift would prevent morin from chelating (or forming the stable quinone moiety). The effect 
of this shift in hydroxyl group position is dramatic, causing the apparent inhibition constant of 
morin to decrease by more than an order of magnitude compared to quercetin. Comparison of 
apigenin to quercetin shows that apigenin, which has the same structure as quercetin except for 
the lack of the 3 and 3’ hydroxyl group, has a loss in apparent binding affinity nearly an order of 
magnitude. 
 Similarly the 3 hydroxyl group is present in all active flavonols. This hydroxyl group 
might participate in hydrogen bonding to one of the residues in the active site, or might contribute 
to apparent inhibition by lowering the oxidation potential. The importance of this group is 
demonstrated in the comparison of luteolin with quercetin. The 
two compounds are identical except for the 3 hydroxyl group 
which luteolin does not have. The effect of this additional 
hydroxyl group can be shown in the comparison of the 
compounds apparent IC50’s, which again show nearly an order of 
magnitude difference. 
 
Figure 2: Proposed binding 
method of active flavonols 
to SOD’s active site. 
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Myricetin, which has a third hydroxyl group on its B ring, shows the greatest inhibitory 
activity for the SOD enzyme compared to the other flavonols examined in this study. We suspect 
this third hydroxyl group participates in hydrogen bonding to a residue in the active site. This 
increased binding affinity for the gallol moiety over the catechol moiety is also apparent in other 
smaller molecules (discussed later).  
From this structure activity relationship, Dr. Summers proposed that the active flavonols 
fit into SOD’s active site and chelate to the copper with the 3’ and 4’ hydroxyl groups, and the 3 
hydroxyl group binds to a residue as shown in Figure 2.   
 
  Flavonol computational work. We used 
the Molecular Operation Environment (MOE) 
program from the Chemical Computing Group to 
dock the nine flavonols shown in Table 4 to the 
active site of an SOD enzyme (1PU0 from the 
PDB). The active site used in this study is shown 
in Figure 3 with a red surface.  
 In the simulation, the nine flavonols in 
Figure 2, were deprotonated at the 4’ position (to correlate to a pH of 8) and docked to the active 
site of an SOD monomer (red surface in Figure 3). Figure 4 shows typical poses when quercetin 
is docked to the isolated active site from Figure 3. Almost all the poses had the flavonols bound 
to residues around the perimeter of the active site. One percent of the docking poses resulted in an 
interaction with the copper atom in the pocket of the active site.  
 
Figure 3: Active site (red) used for the 
docking simulation of the flavonols. 
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For each of the 
docking poses, a 
binding energy was 
generated. As shown in 
Figure 5, the average 
theoretical binding 
energies for each of the 
flavonols did not 
correlate with the IC50 
values determined experimentally. This could be due to the MOE generated poses not being 
representative of the actual way in which the flavonols bind to the enzyme, MOE’s algorithm not 
being designed not handling transition metals, or to active site in the crystal having different 
geometry than in solution. However, it is likely that the discrepancy in the results is caused by 
inhibition being due to redox chemistry 
rather than inhibitor binding. 
The difference in the geometry of 
the active site in the crystal model versus its 
solution analogue was addressed using the 
molecular dynamics (MD) simulation in 
MOE. The simulation examined how freely 
the atoms of the SOD enzyme are able to 
move during normal molecular motion. This 
MD simulation generated poses of the SOD 
every 10 ps during a 10 ns simulation.  From the poses generated, the root mean square distance 
(RMSD) the atoms moved from their original position was calculated and plotted as a function of 
 
Figure 4: Poses of myricetin (left) and quercetin (right) docked to 
the active site (red surface from figure 4). The poses show no 
interaction with the copper atom inside the pocket of the active 
site. 
 
Figure 5: MOE generated relative binding 
energy’s vs. Log(IC50) values obtained 
experimentally. The low R
2
 value (.03) suggest 
there is no correlation between the two values 
27 
 
 
Figure 6:  A) The RMSD movement of chain A of the 1PU0 CuZn enzyme over a 10ns 
MD simulation. B) Movement of the terminal atom of the residues around 1pu0 SOD’s 
active site recorded every 100 ps during a dynamics 10 ns simulation. 
time (Figure 6A). The RMSD values generated with MOE for the 1PU0 CuZn SOD were nearly 
identical to the ones Khare and Dokholyan report21 for wild type SOD using a different software 
package.  
To understand how these motions affect the active site geometry, the movements of the 
residues that “guard” the active site (Figure 7A) were examined.  Figure 7B shows the pose of the 
residues that had the maximum deviation (blue residues) compared to their initial positions (red 
residues). Figure 6B show the distanced moved of the terminal atoms of these residues over the 
course of the simulation. The 
Lys 143 residue demonstrated 
the largest displacement with 
around an 8 Å maximum 
deviation from its initial 
position, and rotating 90 degrees 
out of the active site; while the 
majority of the residues moved 
between 1 and 4 Å.  
  
Figure 7: A) Residues in red “guard” the active site, and 
were examined for movement in the MD simulation. B) 
Residues in red are initial positions. Blue residues are 
the residues at the maximum deviation during the MS 
simulation. Orange arrows show direction of movement.  
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A.                                                                  B. 
Figure 8: A) MOE 3D model of myricetin chelated to the 
copper in SOD’s active site. B) Interactions map of 
myricetin bound in panel A. 
 
 The geometry of the active site opened up during the course of the simulation as shown 
in Figure 7B. Using poses of the SOD with the active site least hindered, the docking simulation 
was performed again. The results of the docking experiment were similar to the first in that they 
showed effectively no poses of flavonols that “fit” into the active site and bound to the copper 
(results not shown).  
Since the MOE program would not generate docking poses that were consistent with 
metal binding, the flavonols were chelated to the copper atom and the energies of the resulting 
system were minimized with MOE’s energy minimization function. After minimizing the energy 
of the system, the binding energies were calculated. From these binding poses, we were able to 
determine that our proposed binding method (Figure 2) is sterically possible and shows favorable 
binding energies. Since the MOEs algorithm does not take into account the added stability a 
chelate provides, the chelate was artificially imposed. However even without the chelate imposed, 
favorable binding energies were observed in poses that were similar to chelated poses, but with 
only one of the flavonol’s hydroxyl groups bound to the copper atom. 
Figure 8 shows typical results of myricetin placed in the active site, chelated to the 
copper. From the 
simulations we saw that the 
residues Arg 143, Gly 141, 
Lys 136, and Glu 133 are 
available to participate in 
hydrogen bonding with the 
flavonol’s 3 hydroxyl 
groups depending on the 
pose, with Lys 136 
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Figure 9: Curvature in the 
concentration vs. 1/Ao-1 plot for 
luteolin. This curvature is believed 
to be due to aggregation. 
interacting most often. Also the extra hydroxyl group on myricetin’s B ring tended to interact 
with the Arg143 residue; which is close enough to the copper atom to allow simultaneous 
chelation to the copper atom and hydrogen bonding to the Arg 143 residue.  
To further investigate the proposed structure activity relationship (SAR), we used the 
MOE program to search a database of 650,000 lead like compounds for compounds that had the 
same essential components (chelating moiety and a flavonol 3 position equivalence) in a similar 
position (within 0.6 Å) as the active flavonols.  From this database, 184 compounds were found 
to be similar to the active flavonols, of which five were selected and purchased. All five of the 
selected compounds were found to have apparent inhibition in the 19F- assay, having IC50’s in the 
100 to 600 μM range. This indicates that other compounds with similar structural features should 
also inhibit the SOD enzyme. Also, we tested compounds that lacked the hydroquinone group for 
SOD inhibition. These were not active inhibitors.  
 
Flavonol aggregation. It has been reported that the aggregation state of flavonols affects 
their activity.13,14   From our inhibition data, we also note that the SOD inhibition activity of the 
flavonols are dependent on aggregation state. Inhibition 
activities appear to decrease as aggregation of the 
flavonols increase.  
For most flavonols, the plots of 

[;<=>?@ABC] − 1 
versus inhibitor concentration were not linear, but 
showed curvature at the higher concentrations (Figure 
9). This indicates that at higher concentrations the 
flavonols are less effective inhibitors than at lower 
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concentrations. We attribute this behavior to aggregation since it is thought that the monomers are 
the active inhibitor. At higher concentrations aggregation of these monomers is occurring and this 
aggregation would therefore remove the active inhibitors from solution, giving a lower activity 
than expected.  
 By plotting the square root of the inhibitor concentration versus  

[;<=>?@ABC]− 1 we are 
able to see a linear relationship for most of the flavonols (Figure 10 shows a representative 
example). From these square root plots, IC50 values 
for each of the flavonols were extrapolated. However, 
to find Kd values we had to quantify amount of 
aggregation that was occurring. 
While the extent of aggregation over the 
entire range of our data is not certain, the square root 
dependence in Figure 10 argues that dimers (Equation 
12) are the major form of aggregates over the 
concentration ranges of the inhibition studies. When 
this is the case the dimerization constant (Equation 13) can be used to find the active inhibitor 
species.  Using equations 12, 13, and 14, equation 15 can be determined from NMR data if Kdim is 
known.  
 2J858J3 ⇌ L4J3 (12) 
 1.'M = L4J3J858J3 
(13) 
  = J858J3 + 2L4J3 (14) 
 −1 ±O1 + 81.'M[]41.'M1. =
1
R%&'() − 1 
(15) 
 
Figure 10: By taking the square root 
of concentration a linear relationship 
can be seen when plotted against 
1/[SODactive]-1.  
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Flavonol aggregation was studied using fluorescence spectroscopy. The fluorescence 
spectra of most of the flavonols showed concentration dependence in the same range as the 
observed curvature in the plots of  

[;<=>?@ABC]− 1 versus inhibitor concentration (Figure 11A). The 
fluorescence spectra were normalized to the area under the curve to account for inner filter 
effects. Using multiple wavelengths the fluorescence data for each of the flavonols were fit, using 
the method of least squires, to the best fit values of the dimerization constant (Figure 11B), (some 
of the flavonols showed no variance in the fluorescence spectrum so the Kdim was not found). 
This dimerization constant and NMR data was then used with equation 15 to find the Kd’s of the 
flavonols.  
A principal component analysis was performed to determine the validity of our 
assumption that dimerization is the extent of aggregation on the fluorescence spectra of each 
flavonol. This analysis was done by using the factorization technique of singular value 
decomposition (SVD). The SVD method factors an n by m spectral matrix A (where n is the 
   
Figure 11: A) Fluorescence spectra of myricetin over the concentration range of 1 to 256 
µM. B) Least squares analysis using 514 and 543 nm fluorescence data to calculate Kdim. 
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number of spectra and m is the area normalized fluorescence intensity at a given wavelength), 
into an orthogonal basis set of its column and row vectors S and UT respectively, and where V is 
a diagonal matrix of the singular values arranged by decreasing size (equation 16). The column 
vectors in UT represent the principal components of the spectral data in decreasing order of 
significance. For a two component system, only the first two columns of UT would represent 
principal components, the rest of the columns in UT would represent noise in the data.  
   (16) 
 
 
 
By decomposing A into the SVUT factorization, and then recalculating A using only the 
desired number of principal components (for an n component system using only the first n rows 
of UT and n columns of the product of SV) the number of principal components can be analyzed 
by the percent of A represented by Acalc. This was done using equation 17 (where ∑A and ∑Acalc 
is the sum of all the components of the respective matrix). 
 %	T	3U3V5!L = W1 − |∑R&%+& −∑R||∑R| Z ∗ 100 
(17) 
 
m x m 
n x m 
A S V U
T 
n x m 
m x m 
Equation 16: SVD decomposition of the spectral matrix 
A. Red lines/box represents the intuitive orientation of 
the data in the respective matrices.  
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While the number of pure components 
(species in solution) may in theory be different 
than the number of principal components 
(those with independent spectra). The 
evidence suggests that two principal 
components account for the vast majority of 
the compounds over the concentration range 
studied.* 
In the concentration range where the 
monomer and dimer are the only species, each 
fluorescence spectrum contains only two pure 
components. Therefore calculating Acalc using only 
two principal components should regenerate A 
with nearly 100 percent of the data represented.  
The percentage of the flavonol 
fluorescence data (A) represented by Acalc using 
only two principal components was calculated 
starting with the spectrum that represented the 
lowest concentration, then recalculating with each 
additional spectrum that represented the next 
highest concentration. Figure 12 shows this 
                                                           
* This could occur when a pure species has no spectral response, or because a pure species is not 
linearly independent over the range of the spectra (i.e. shows a constant spectral response).  We 
assumed that the linearly independent species at the lower end of the concentration range is the 
monomer, and the next spectral species with increasing concentration is the dimer. Since the 
dimerization model gives a good fit to our NMR assay results in this concentration range, this 
assumption is thought to be valid. 
 
Figure 12: Percentage convergence of 
Myrocetin’s fluorescence data using only 
two principal components. 
 
Figure13: Concentrations to which the 
principal component analysis using 2 
components accounted for all the 
significant variance in the fluorescence 
data for each of the flavonols. 
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analysis preformed on the myricetin data. This data could be represented by two principal 
components with 99 percent accuracy up a concentration 64 μM myricetin. Above this 
concentration the percent convergence started to drop off quickly indicating the addition of 
another species.  
 This principal component analysis shows that 2 principal components could only account 
for the variance in the fluorescence data in the lower concentrations for the flavonols. Figure 13 
shows the concentration to which the variance in the fluorescence data could be accounted for by 
two species. Above these concentrations the percent convergence began to drop sharply as shown 
in higher concentrations in Figure 12 (due to different amounts of noise in the data the percentage 
at which this occurred varied). 
 
Inhibition by low molecular weight phenolic compounds. The structure activity relationship 
developed from the flavonol experiment led us to study interactions of the enzyme with smaller 
molecules having the essential components for binding. These components included a catechol or 
gallol group able to bind to the copper and a hydrogen bond donor/acceptor in a similar position 
as the 3 hydroxyl group in 
the flavonols. 
We looked at 
several compounds that fit 
these criteria. Some of the 
more effective inhibitors are 
shown in Figure 14. While 
many of the compounds 
Compound IC50 Compound IC50 
 
2’,4’- 
Dihydroxyacetophenone 
 
≈2.5 mM  
Methyl 3,4- 
Dihydroxybenzoate (MDHB) 
 
≈1 mM 
 
2,3-Dihydroxybenzoic acid 
 
≈5.5 mM  
Methyl 2’,3’,4’- 
Trihydroxybenzoate (MTHB) 
 
≈0.5 mM 
 
3,4-Dihydroxybenzoic acid 
 
≈1.5 mM  
Gallic acid (GA) 
 
<0.1 mM 
Figure 14: Small phenolic compounds that we have 
investigate, and show activity against SOD.   
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showed some apparent SOD inhibition, the most effective inhibitors had the gallol moiety. This 
was also observed in the flavonols that were studied, where myricetin was most active. We note 
that the compounds without the ability to chelate showed higher IC50 values then the compounds 
that could chelate (IC50 was used rather than Kd because the aggregation observed in these 
compound has not been investigated). (As for 2,3-dihydroxybenzoic acid, which appears to be 
able to chelate, its IC50 is thought to be much higher than other chelators because of steric 
interactions with the active site hindering its ability to chelate to the copper.) This is also 
supported with MOE modeling which generated poses with either the carboxylic acid or 3 
hydroxyl (depending on how the chelation is 
imposed) clashing with the walls of the active 
site when chelated to the copper.  
 To address the question of whether or 
not our compounds were binding to the SOD 
enzyme in the manner predicted (by chelating to 
the copper in the active site) or inhibiting 
through another mechanism; we synthesized six 
isomers of pental gallate (Figure 15).  We 
reasoned that if the compounds inhibited by binding to the copper in the active site, then the 
esters with bulkier alkyl chains (i.e. neopental gallate and 3-pental gallate) should show a lower 
binding affinity for the enzyme than esters that have straighter alkyl chains. This is because the 
bulkier esters would encounter steric hindrance while trying to fit into the pocket of the active 
site. 
 
1-Pentyl Gallate 
 
3-Pentyl Gallate 
 
2-Methyl-1-butyl Gallate 
 
Neopentyl  Gallate 
 
Isoamyl Gallate 
 
3-Methyl-2-butyl Gallate 
Figure 15: Synthesized isomers of pentyl 
gallate. The bulkier the alkyl chained 
esters shows lower binding affinity then 
the straighter alkyl chained esters. 
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 To test our hypothesis, 
the binding affinity of the 
gallate esters were first 
calculated using the MOE 
program. This was done by 
placing the compounds in 
SOD’s active site in such a way 
that they chelate to the copper 
by their 3 and 4 hydroxyl 
groups; then the energy of the 
system was minimized with the 
MOE energy minimization 
application. The MOE program 
was used to calculate the 
binding energies of the lowest energy state for the bound ligand. The computational results 
supported our hypothesis that the bulkier esters were sterically hindered from fitting into the 
pocket of the active site; leaving the hydrophobic alkyl chain in the aqueous surroundings, and 
lowering their binding affinity. The more flexible, straighter chained esters were able to conform 
to the contours of the active site, allow the alkyl chains to fit into the hydrophobic pocket of the 
enzyme (Figure 16). 
 The esters were prepared and tested for inhibition against the enzyme using the 19F- NMR 
assay previously described. While the concentration dependence of inhibition was consistent with 
aggregation of the inhibitors, assuming the aggregation constants are similar, the relative binding 
affinities from the experimental data correlate with the calculated binding results from the MOE 
program (Figure 17). This correlation between the experimental and calculated results suggest 
 
 
Figure 16: MOE modeling of 1-pental gallate (top panel), 
and Neopetyl gallate (bottom panel). The modeling show 
the bulkier alkyl chain is less able to fit into the active site 
then the straight chained 1-pently gallate. 
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that the MOE poses that were used in the 
calculated results are representative of the 
actual inhibition method, supporting the 
hypothesis that the compounds must fit into 
the pocket of the active site to inhibit the 
NMR activity.   
 
The pH dependence of inhibition. It 
has been reported that SOD’s catalytic 
activity is constant in the pH range from 5 to 
10.16 However, our inhibition data shows a 
pH dependence within this 5 to 10 pH range. We attributed this variation to the protonation state 
of the inhibitors. When the pH increases above 10, it is thought that one of the residues in SOD’s 
active site is deprotonated making the enzyme more vulnerable to inhibition.16  
To see how the protonation state of 
an inhibitor affects inhibition Sherri 
Barborich, a member of our group, looked at 
inhibition over the 5 to 10 pH range where 
SOD activity is constant. The compound used 
for this experiment was 3’,4’,5’- methyl 
trhihydroxybenzoate (MTHB, Figure 14) .16 
MTHB has its first pKa at 7.88 for its 4’ 
hydroxyl group which is at one of its metal 
chelating positions.17 Figure 18 shows the 
 
Figure 17: Predicted (MOE calculation) 
versus experimental (19F assay) binding 
data for the synthesized esters. The 
correlation suggests the proposed binding 
method is accurate.  
 
Figure 18: pH dependence on enzyme 
inhibition (diamonds) correlating to 
deprotonation of MTHB’s 4’ hydroxyl group 
(line). 
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enzyme activity with 60 μM MTHB, as well as the percentage of deprotonated MTHB, in the pH 
range of 6 to 9. Our results demonstrate that as the percentage of deprotonated MTHB increases, 
the percent of active enzyme decreases. Furthermore, when MTHB is fully protonated there is 
nearly no inhibition.  
Figure 19 shows an identical experiment run with Gallic acid (GA Figure 14). GA has its 
first pKa at 3.13 for its carboxylic acid, and its second pKa at 8.84 for its 4 position hydroxyl 
group.17 In the pH range of the experiment, GA’s carboxylic acid is fully deprotonated. However 
from the inhibition data (Figure 19) it is 
apparent that it is not until deprotonation 
of the 4 position hydroxyl group, which is 
in a copper chelating position, that 
inhibition occurs. These results indicate 
that deprotonation at one of the catechol 
hydroxyl groups is essential to inhibition 
and that deprotonation at non-metal 
binding sites has little effect on inhibition. 
However, deprotonation in non-metal 
binding sites would affect the solubility 
and aggregation state of inhibitors. 
 
SOD inhibition mechanism. We investigated four possible mechanisms by which low 
molecular weight compounds could inhibit the 19F NMR activity of SOD. They could act by an 
aggregate mediated mechanism, by blocking the active site, metal sequestering or by reducing the 
 
Figure 19: The pH dependence of inhibition for 
GA is due to the deprotonation of the 4 position 
hydroxyl (pKa 8.84) and not the carboxylic acid 
(pKa 3.13); showing the importance of 
deprotonation in a metal binding site. 
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paramagnetic copper atom. Results of 
this study indicate reduction of 
diamagnetic copper to be the cause of 
the loss of 19F NMR activity.  
 
Studies of aggregate based 
mechanism. It has been reported that 
quercetin forms aggregates that are 
large enough for the enzyme β-
lactamase to bind too through van der 
Walls forces.15 Inhibition can occur as 
enzymes bind to these aggregates and 
then become partially denatured.13  
To test whether flavonols inhibit by this mechanism we examined the inhibition of 30 μM 
quercetin over a six-fold concentration range of SOD. If inhibition involves inhibitor aggregates, 
then inhibition constants should be dependent on the concentration of SOD.14 This dependence on 
SOD concentration is due to the aggregates becoming saturated with enzyme. Figure 20 shows 
the fluoride relaxation rate of controls with no quercetin (blue diamonds) and samples with 30 
μM quercetin (red squares). From this data it can be seen that, within experimental error, the 
apparent enzyme activity in the sample with quercetin retains around 40 percent activity 
compared to the control sample. This constant inhibition percentage regardless of SOD 
concentration indicates that inhibition of SOD by quercetin does not occur by an aggregation 
based method in this concentration range. Since both the Kd’s and Kdim are on the same order of 
Figure 20: Six fold SOD concentration dependence 
on Quercetin inhibition. The inhibition remained 
constant at around 60%, suggesting inhibition is not 
occurring by aggregation. 
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magnitude for all the active flavonols, this 
result for quercetin is likely to hold for the 
other active compounds as well.  
It has been reported that catechols 
form stable metal complexes.27 Also the 
compound quercetin is known to bind copper 
via its catechol group.28 From this we 
hypothesized that inhibition of SOD may 
occur by metal binding and subsequent 
sequestering of the copper from SOD’s active 
site. To address this we looked at whether or 
not sequestering was occurring for the 
compound MDHB at pH 8. If sequestering by MDHB was occurring, it would also suggest that 
compounds that have a higher affinity to copper could inhibit by sequestering the copper from 
SOD. 
To investigate whether or not sequestering was occurring we used inductively coupled 
plasma optical emission spectroscopy (ICP-OES) to determine copper concentrations of SOD 
solutions with and without MDHB. In these experiments solutions were allowed to equilibrate 
overnight to ensure adequate time for reaction to occur. Solutions were prepared either with or 
without MDHB and fractionated with a Millipore YM-10 centrifugal concentration device. This 
excludes species larger than 10,000 Daltons. Since the SOD has a molecular weight of 32,500 
Daltons, the YM-10 filter should retain the SOD, but allow low molecular weight copper 
complexes to pass through. Once separated, the copper concentrations were determined by ICP-
OES.  
 
Figure 21: Copper concentrations of SOD 
solution without (control) and with MDHB 
before and after filtering with an YM-10 
filter. The similar concentrations between the 
control and MDHB solutions suggest metal 
sequestering is not occurring. 
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Figure 21 shows the ICP-OES results from this experiment. Within experimental error, 
addition of MTHB did not lead to an increase in copper in the low molecular weight fraction of 
the control (73 and 78 percent respectively of the copper removed by the filter). This indicates 
that inhibition by MDHB does not result from sequestration of the copper from SOD. 
 
Thiol vs. Hydroxyl inhibition. Since sulfur has a greater affinity for copper then oxygen, 
substituting sulfurs for hydroxyl groups 
in metal binding sites of inhibitors 
should increase inhibition; if inhibition 
involves binding to the copper in SOD’s 
active site. 18 
 To test this hypothesis we 
looked at catechol, and two thiolated 
derivatives: 2-mercaptophenol, and 1,2-benzenedithiol (Figure 22). Figure 22 shows the SOD 
activity as a function of each of the inhibitor concentrations. The data in Figure 22 shows that as 
the hydroxyl groups are replaced by sulfurs apparent inhibition increases. We note that sulfur’s 
greater reduction potential could also cause the increase in apparent inhibition. 
 
     
Figure 22: SOD inhibition by catechol and 
thiolated derivatives. The data show that by 
substituting hydroxyls for thiols, inhibition 
increases.  
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SOD redox reaction with inhibitors. To investigate whether inhibitors bind to copper in 
SOD’s active site, we collaborated with the research group of Julia L. Brumaghim from Clemson 
University to determine whether inhibitors affect the EPR signal of the copper in SOD. Figure 23 
shows EPR data for MTHB (Figure 23 A and B) and MDHB (Figure 23 C and D) with copper 
(II) at pH 8 and 11. Before adding inhibitors, the EPR signal consists of a series of peaks for the 
oxidized, paramagnetic form of the copper. Upon addition of MTHB the spectrum changes to a 
series of lines at different frequencies and slowly decays with time, virtually disappearing after 24 
hours in the MTHB samples.  The change in signal indicates change in the coordination 
environment of the copper, presumably binding MTHB. The decay of the signal indicates that the 
copper has been reduced to the diamagnetic +1 oxidation state. In contrast, signal is not lost in the 
 
Figure 23:  EPR spectra of CuCl2 without polyphenol (1); with polyphenol after 1 min (2); 
with polyphenol after 1 h (3); and with polyphenol after 24 h (4) for A) MTHB at pH 8; 
B) MTHB at pH 11; C) MDHB at pH 8; and D) MDHB at pH 11. 
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MDHB treated samples. Figure 24 shows a similar experiment where SOD was used instead of 
copper (II). The data in Figure 24 also shows a reduction in the intensity for the copper (II) peak 
upon incubation with MTHB at both pH 8 and 11and MDHB at pH 11. At pH 8, treatment with 
MDHB shown a new set of frequencies similar to those observed with MDHB and free copper 
(II) at pH 8 indicating coordination to the copper. While this could indicate lose of copper (II) 
from SOD, filtration experiments data indicates that this is not occurring.  We conclude that 
compounds bind copper in SOD’s active site and undergo an election transfer to reduce the 
copper (II) in SOD. 
The reduction of the copper in the presence of these inhibitors raises the question: does 
the redox activity of the inhibitors determine their effectiveness as SOD inhibitors in the 19F 
 
Figure 24:  EPR spectra of Cu,Zn-SOD without polyphenol (1); with polyphenol after 1 
min (2); with polyphenol after 1 h (3); and with polyphenol after 24 h (4) for A) MTHB at 
pH 8; B) MTHB at pH 11; C) MDHB at pH 8; and D) MDHB at pH 11.   
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NMR assay?  
 If the flavonols are coordinating with, and reducing the copper (Equation 18) as 
suggested by the MTHB and MDHB EPR data, inhibition constants should be related to the 
oxidation potentials of the flavonols by Equation 20. Pietta19 noted that the antioxidant activities 
of flavonols have a SAR that is nearly identical to the SAR we developed for SOD inhibition by 
flavonols. 
 5ℎ474!83]= + #$<^ 	⇌ 5ℎ474!83<^ + #$]= (18) 
 _-̀ = 5 a51 
(19) 
 _bc'	<` = −5 a51 + _;<=	]=  
(20) 
 _bc'	<` = 5 lnde + _;<=	]=  
(21) 
 
Figure 25 shows our experimental IC50 values plotted against published half peak 
oxidation potentials20 (IC50’s were used rather than Kd because dimerization constants were not 
found for all the flavonols of interest. Since IC50 is proportional to 1/K, Equation 20 can be 
modified to give equation 21). Figure 25 shows a linear relationship between our experimental 
IC50 data and half peak oxidation potentials, with a slope of 35.3 mV. This value of 35.3 mV 
found by the slope of the graph in Figure 25 
is close to the value of  
f
g  (25.69 mV 
assuming n=1). This shows that the 
apparent inhibition correlates with the 
reduction potential of the flavonols. 
Since the EPR data shows copper 
being reduced from the oxidized 
 
Figure 25: Flavonol NMR inhibition correlates 
with oxidation potentials. 
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paramagnetic copper (II) to the diamagnetic copper (I) form, and since the reduction potential of 
the flavonols correlates with apparent inhibition, we hypothesized that inhibitors might only 
reduce the copper and not block SOD’s active site. This reaction would account for the observed 
inhibition in the 19F- NMR assay, since the diamagnetic form of the copper does not affect the 
fluoride’s relaxation rate. We note that inhibition of NMR assay by this mechanism would not 
cause loss of SOD’s enzymatic activity since the copper (I) form is an intermediate in the 
catalytic cycle. 
To test whether the compounds affect SOD’s redox cycling, we conducted an experiment 
where partially inhibited enzyme was treated with compounds known to generate superoxide 
(NADH and PMS). In the absence of inhibitor, superoxide reacts with the SOD as described by 
Equations 3 and 4. In the reaction with O2˙	,	
SOD cycles between oxidized and reduced 
forms and reaches a steady state where the 
ratio of paramagnetic to diamagnetic copper 
is constant. This ratio can be monitored with 
the 19F- CPMG experiment. If an inhibitor, 
such as quercetin, binds to and blocks the 
active site of the SOD, then inhibited SOD 
will be effectively removed from solution 
and the addition of NADH/PMS will cause 
the remaining uninhibited SOD to react with the O2˙	and reach a steady state having the same 
percentage paramagnetic and diamagnetic copper as the solution without quercetin. In contrast, if 
quercetin does not inhibit SOD activity, then the addition of NADH/PMS will cause the solution 
to reach the same steady state as solutions without quercetin.  
Figure 26: Effect of O2
.- on the oxidation state 
of SOD, and SOD with 30 µM Quercetin over 
time. 
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Figure 26 shows the experimental data from the SOD redox experiment. The black 
squares in this figure show the effect of O2˙ on 19F relaxation by SOD. As shown, in the absence 
of inhibitor, a steady state is reached with around 30 percent of the SOD in the paramagnetic form 
in the absence of quercetin. The red triangles show the results of the same experiment performed 
in the presence of quercetin. The red triangle at time zero shows that prior to addition of 
PMS/NADH the SOD relaxation in the quercetin sample was approximately 40 percent that of the 
control. The black line shows the predicted behavior for the case where quercetin bound to and 
blocked the active site and the remaining uninhibited SOD reached a steady state with 30 percent 
paramagnetic copper. The red triangles show the actual behavior of a 30 μM quercetin solution 
upon addition of NADH/PMS. As shown in Figure 24, the quercetin containing sample reached 
the same steady state as the sample without quercetin (within experimental error) when treated 
with O2˙.  This result is consistent with the hypothesis that quercetin reduces the copper to the 
diamagnetic form and that the diamagnetic form retains its enzymatic activity. 
 
 
Studies on Superoxide Dismutase Inhibition Conclusion 
 
Using the 19F- assay, we have found that a number of flavonols and small phenolic and 
thiol compounds inhibit SOD's NMR relaxation activity. The apparent inhibitory activities of 
these compounds show a dependence on their structure, aggregation state, and pH. However this 
apparent NMR inhibition did not correlate with inhibition of the enzyme’s activity. We believe 
that NMR activity results from reduction of the copper in the active site. 
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The activity of the flavonols was found to depend on the presence of the 3, 3’ and 4’ 
hydroxyl groups which were present in all the active compounds. From these structure activity 
relationships we hypothesized that the flavonols bind to the enzyme by chelating to the copper 
atom in the active site with the 3’ and 4’ hydroxyls and that the 3 position hydroxyl group 
participated in hydrogen bonding to one of the residues in the active site. Using computational 
software, it was determined that our proposed mechanism was viable, and produced favorable 
binding energies. However, our hypothesis for the binding method has been shown to be 
incorrect; or at least insignificant because the inhibitors do not bind to the active site, but rather 
reduce the copper without permanent binding.  
From the 19F- assay we noted that as the concentration of some of the inhibitors increased, 
their effectiveness as inhibitors decreased. This behavior was attributed to aggregation. The 
fluorescence spectra of these compounds, which showed concentration dependence in same range 
as in the 19F- assay. From the dependence of the fluorescence spectra on concentration, we 
characterized the aggregation of most of the flavonols we studied. Principal component analysis 
indicated that dimerization alone cannot account for the aggregation observed in the higher 
concentrations of our assay. At the lower concentrations, however, the monomer/dimer 
equilibrium represented our data well.  
The inhibitors activities were also pH dependant. We have shown that below pH 10, this 
pH dependence arises from the deprotonation of the inhibitors, and that the activity of the enzyme 
is more or less constant. 16 This behavior might be attributed to the increased solubility or affinity 
for a negatively charged inhibitor for the copper cation, or to the oxidation of the inhibitors 
becoming more thermodynamically favored once they are deprotonated.  
While we initially thought that the NMR inhibition was due to binding of the inhibitors to 
the copper inside SOD’s active site, the EPR and superoxide reactivity studies indicate that this 
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apparent anti-SOD activity arises from reduction of SOD’s paramagnetic copper to diamagnetic 
copper. The observation that samples with and without an inhibitor reaches the same steady state 
after addition of superoxide generating species (NADH and PMS) shows that the compounds did 
not inhibit the enzymatic activity of the SOD.26  
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APPLICATION OF METHODS TO STUDY METAL ION PARTICIPATION IN 
COMPLICATION OF DIABETES  
 
 
Studies of Species Implicated in Complications of Diabetes Background 
 
Diabetics display increased chemical modification of proteins and lipids that occur 
through the Mallard reaction with sugars. For proteins, this leads to the formation of advanced 
glaciation end-products (AGEs).22 Products of reactions with lipids are called advanced 
lipoxidation end-products (ALEs).23 While most modifications of proteins involve amine groups, 
Alderson et al.24 reports that the chemical modification of sulfhydryl groups also occurs.24 This 
modification appears to occur by a Michael addition of sulfhydryl groups to the Krebs Cycle 
intermediate fumarate (Equation 22). The product of this reaction is a S-(2-Succinyl)cysteine 
(2SC) modified protein.28 Since glutathione concentrations in vivo can reach up to 10 mM it 
seems likely that reduced glutathione would also react with fumarate to give S-(2-succinyl)-
glutathione (2SGT, Figure 27B).31 In diabetic patients concentrations of AGE/ALE correlate with 
concentrations of modified sulfhydryl groups. This protein modification might arise due to the up 
regulation of fumarate in diabetics due to impaired mitochondrial metabolism.24    
 
SHR +
O
OH
O
OH
S
R
O
OH
O
OH
 
 
(22) 
 
Protein Sulfhydryl Fumarate 2SC Modified Protein 
50 
 
Since succinic acid binds 
metals with a log(K) = 6.88 for 
iron (III) and log(K) = 2.6 for 
copper (II), and copper succinate 
is known to catalyze the 
disproportionation of superoxide, 
it has been proposed that 2SC 
modified proteins in vivo might 
influence oxidative stress by 
binding metal ions.25, 34 In this study we investigated the possibility that the 2SC/2SGT species 
bind metals in a way that allows them to participate in metal catalyzed reactions.  
We synthesized S-(2-succinyl)-N-acetlycysteine (2SAC, Figure 27) and 2SGT to study 
metal binding by cysteine residues and their subsequent redox chemistry.  
We were specifically interested in redox activates of metals bound to 2SAC/2SGT. These 
reactions include of superoxide cycling (Equation 1 and 2) and the Haber-Weiss Cycle (Equations 
3 and 4) which produces the hydroxyl radical.  The ability of these metal complexes to catalyze 
the Haber-Weiss cycle is of particular interest since complications of diabetes have been linked to 
increased oxidative stress.  
Reactions of 2SAC-Cu complexes with superoxide are likely to require access of solution 
to the metal center. We used 19F NMR methods to determine whether the metal ion is accessible 
to solution. Earlier we have shown that the 19F- ion can predict rates at which metal complexes 
react with superoxide radicals. The 19F NMR resonance is highly affected by the presence of 
paramagnetic metals (discussed above for SOD inhibition). If fluoride can contact the metal, then 
     
A)                                                 B) 
Figure 27: Synthesized compounds used to study 
possible 2SC reactions in vivo. A) S-(2-succinyl)-N-
acetlycysteine B) give S-(2-succinyl)-glutathione. 
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other small molecules such as superoxide and H2O2 should be able to as well, and, if 
thermodynamically possible, undergo metal catalyzed redox reactions.  
Electrochemical behaviors of the 2SAC/2SGT compounds were studied using cyclic 
voltammetry. As described by Boukhalfa et al.29 a metal complex with a redox potential between 
-160 and +460 mV vs. NHE may catalyze the Haber-Weiss Cycle (Equations 1 and 2).  
Reactions of 2SAC and 2SGT copper complexes with superoxide were studied with 19F 
NMR. The production of the hydroxyl radicals from hydrogen peroxide was studied by 
monitoring the effects of 2SAC/2SGT-Cu on the visible spectrum of rhodamine B.  
 
 
Application of Methods to Study Metal Ion Participation in Complication of Diabetes 
Experimental 
 
 
2SAC synthesis. Maleic acid (Sigma-Aldrich) and N-acetyl-L-cysteine (Alfa Aesar) 
were obtained and both used without further purification. Approximately 2 g of maleic acid and 
c.a. 2.8 g of N-acetyl-L-cysteine (4:3 ratio of maleic acid to N-acetyl-L-cysteine) were dissolved 
in c.a. 50 mL of H2O and the solution was adjusted to a pH of 7.4 with 1 M NaOH. The solution 
was stirred under inert atmosphere and low heat (c.a. 35 ˚C) for 48 hr. The solution was then 
acetified to a pH of 0.9 with 2 M HCl and put into a separatory funnel. The solution was then 
washed 5 times with ethyl ether to remove excess maleic acid. The solution was transferred to a 
RBF and the solvent removed under reduced pressure to give a white solid. Acetone was added to 
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the crude product to dissolve the desired product while leaving NaCl as a precipitate. The solid 
NaCl was filtered off and the filtrate evaporated under reduced pressure leaving behind the 
desired 2SAC product. Products were characterized by 1H and 13C NMR and Mass Spec. The 1H 
NMR assignments in figure 28 were established by COSY, HSQC, and HMBC NMR (Appendix 
B).  
 
                                     
 
Peak Shift (ppm) 
a 2.08 
b 4.69 
c 3.11 
c’ 3.28 
d 3.83 
e 2.88 
e’ 3.00 
Figure28: 1H NMR spectrum assignments for 2SAC. For peaks c and e stereochemistry was 
not assigned. 
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2SGT synthesis. Maleic acid (Sigma-Aldrich) and reduced glutathione (Amresco) were 
obtained from commercial sources and used without further purification. Maleic acid (2 g) and 
c.a. 4 g of glutathione (4:3 ratio of maleic acid to glutathione) were dissolved in 50 mL of H2O 
and the solution was adjusted to a pH of 0.9 with 2 M HCl. The solution was stirred under 
vacuum and low heat for 48 hr. The solution was then transferred to a separatory funnel and 
washed 5 times with ethyl ether to remove excess maleic acid. The solution was evaporated under 
reduced pressure to give a 2SGT as a white solid. The product was confirmed by 1H and 13C 
NMR and mass spectrometry. The 1H NMR assignments are given in figure 29. The 1H NMR 
assignments given in figure 29 were determined by COSY, HSQC, and HMBC NMR (Appendix 
B). 
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Peak Shift (ppm) 
 
a 4.63 
b 4.07 
c 4.00 
d 3.78 
e 3.22 
e’ 3.02 
f 2.95 
f’ 2.81 
g 2.57 
h 2.22 
 
Figure 29: 1H NMR spectrum assignments for 2SGT. For peaks e and f stereochemistry was 
not assigned. 
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Determination of acid dissociation constants (pKas) for 2SAC and 2SGT. Protonation 
constants of 2SAC and 2SGT were found by titration of a 10 mM solution of either 2SAC or 
2SGT with a sodium hydroxide solution while moitoring the pH (Hanna Instruments HI2215). A 
detailed description of the experimental setup is given in Appendix C.  The ionic strength was 
mantained at 0.1 M with either KNO3 or KCl. The filled black diamonds in Panels A and C of 
Figure 30 shows representative titrations of 2SAC and 2SGT with sodium hydroxide. From the  
titraiton curve three protonation constants were found for 2SAC. These are attributed to the 
deprotonation of 2SAC’s three carboxylic acids. Five protonation constents were found for 
2SGT, corrosponding to the four carboxylic acids and the amine. The equilibrium equations for 
 
 
Figure 30: Effects of added base on pH of solutions containing 2SAC and 2SGT 
(A) 
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these  reactions can be described by Equation 23 where LHi is an acidic protonatied species L, 
with i acidic protons.    
 
 ' +  ⇌ ' (23) 
 
The equilibria, described by equation 23, are subject to mass balance  described in Equation 24 
and are characterized by the protonation equilibrium constants (KHi, Equation 25) can be found.  
 []%+ =  '
'
 (24) 
 1' =
[']
['][] 
(25) 
  
Protonation constants for 2SAC and 2SGT were determined from the titration curves 
using the n̅̅̅̅  method.30 According to this method n̅̅̅̅  is defined as the average number of acidic 
protons bound to an acid and is described by Equation 26.30 Experimentally n̅̅̅̅  can be found at 
any point in the titration by subtracting the number of free protons from the total number of 
available protons and dividing by the total ligand concentration.  As described in Equation 27, n̅̅̅̅  
is calculated by adding the number of acidic protons on the acid, j (e.g. for a diprotic acid j=2), to 
the number of protons from the dissociation of water minus the amount of  sodium hydroxide 
added minus the amount of free protons. By rearranging equations 24 and 25 n̅̅̅̅  can also be found 
using protonation constants and pH,  and is given by Equation 28 (β is the term for the 
cumulative protonation constant e.g. β2 = KH1KH2). 
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Protonation constants were estimated using Solver® (Excel 2011) to minimize the sum of 
the squares of the residuals between the experimental and calculated values of n̅̅̅̅. Experimental 
and calculated values of n̅̅̅̅  after optimization are compared in panels B and D of Figure 28 
for representative titrations of 2SAC and 2SGT respectively.  
 
Stoichiometry of 
copper(II)-ligand complexes. 
Stoichiometries of the metal ligand 
complexes were determined using 
Job’s method of continuous 
variation.32 We measured the 
absorbance spectra of solutions 
containing different metal to ligand 
ratios while keeping the total 
concentration of the two species 
constant. As shown in Figure 31, both 
2SGT and 2SAC showed the greatest 
absorbance when the ratios of copper 
  = ∑ 4['][]%+  
(26) 
  = []%+ + [
	] − [] − []
[]%+  
(27) 
  = '[
]
∑ '[]''  
(28) 
A)  
B)  
Figure 31: Job’s method data for 2SAC/2SGT and 
copper (II) 
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to ligand was 1 to 1. The experiments were performed at a pH of 5 so that the carboxylic acids of 
the major species were fully deprotonated. Since the stoichiometry for both metal complexes was 
found to be 1:1 the equilibrium equations for the 2SAC/2SGT copper binding is given by 
Equations 29 and 30. From the equilibrium equations, equations for the stability constants (K2SAC-
Cu and K2SGT-Cu) are given by Equations 31 and 32. 
 
 2SAC	 + Cu ⇌ (2SAC − Cu)	 (29) 
 2SGT	 + Cu ⇌ (2SGT − Cu)	 (30) 
 K	 =
[(2ASC − Cu)	]
[2SAC	][Cu] 
(31) 
 K	 =
[(2SGT − Cu)	]
[2SGT	][Cu]  
(32) 
 
 
Determination of copper/ligand complex stability constants. Stability constants for 
copper (II) binding by 2SAC and 2SGT were determined by titrations of equal molar ligand and 
copper (II) (2 mM each) with sodium hydroxide whilst monitoring both pH (Hanna Instruments 
HI2215) and the UV/Vis spectra (BW-Tek i-Trometer using a BD5130 UV/Vis/NIR light 
source). A detailed description of the procedure is given in Appendix C. The ionic strength was 
maintained at 0.1 with either KNO3 or KCl. Stability constant were demined from the titration 
data using a method similar to Bjerrum’s.30 While we attempted to determine the stability 
constants for 2SAC  and 2SGT complexes of iron (II), a precipitate formed at approximately pH 
2-3. The copper complexes of 2SAC and 2SGT were more amenable to work with, remaining 
soluble up to a pH of approximately 6 for 2SAC and throughout the titration (pH of 13) for 
2SGT.  
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The concentrations of species present during the titration were determined from UV/Vis 
spectra using an Alternating Least Squares Multi Curve Resolution (ALS-MCR) algorithm in the 
Matlab program (Appendix A). This algorithm begins be estimating extinction coefficients of 
absorbing species (using the initial and finial spectra from the titration). Concentrations of each 
species at each point in the titration were calculated using Beer’s law, using the experimental 
spectra and the estimated extinction coefficients of for the pure species. Constraints were applied 
to prevent the calculated concentrations from becoming negative and to maintain mass balance. 
The spectra for the pure components were then recalculated from the experimental spectra using 
the newly found concentrations. The calculated concentrations and extinction coefficients were 
used to predict the observed spectra. The difference between the experimental and calculated 
spectra was minimized by repeating this process until the calculated spectra were within a 
specified tolerance of the experimental spectra.  
The ALS-MCR algorithm requires that the number of absorbing species be known. A 
Principal Component Analysis (PCA) of the spectra was performed to determine the number of 
absorbing species present when 2SAC is titrated in the presence or absence of copper (II). This 
analysis was described earlier for flavonol aggregation (algorithm given in Appendix A). As 
   
Figure 32: UV/Vis spectra for A)2SAC B) 2SAC and copper (II).  
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shown in Figure 32A, the UV/Vis 
spectra of 2SAC in the absence of 
copper (II) changes very little during 
titration with base. From this 
experiment the principal component 
analysis found that 96% of the 
spectra could be accounted for with 
just one absorbing component 
(Figure 33). In contrast, two components are required to account for the spectra when one 
equivalence of copper is present (Figure 32B). In this experiment, 97% of the spectra could be 
accounted for with two species. No significant increase in the fit was observed with more than 
two species for either titration. This indicates that 2SAC and 2SAC-Cu are the only two 
absorbing species are present in the 2SAC-Cu titrations.  
The concentrations of each 
absorbing species in the titrations were 
calculated using the ALS-MCR algorithm. 
Figure 34 shows the fraction of species 
obtained from this calculation on the 
2SAC-Cu data and is shown overlaid on 
the experimental pH data for one of the 
titrations. 
From the spectra, concentration of the metal complex ([L-metal]) can be determined for 
each pH and, the concentration of unbound ligand ([L]free) can be found from the mass balance 
equation (Equation 33). 
 
Figure 34: Fraction of each species calculated 
for titrations of 2SAC-Cu overlaid on the 
experimental pH data. 
 
Figure 33: Principal component analysis for 2SAC 
and 2SAC-Cu(II) spectra 
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 []¡-)) = []%+ − [ − J!a] (33) 
 
The concentration of the unbound ligand in any of its protonation states can be found by Equation 
34 which uses [L]free, the pH, and the protonation constants.  
 ¢ =
[']
[]¡-)) =
'[]'
∑ '[]'£  
(34) 
 
Where α is the fraction of species, βHi is the ith cumulative protonation constant (e.g. βH2 = KH0 * 
KH1 *K H2), and βH0 = 1. 
To find the copper (II) stability constants described in Equations 31 and 32 another term θ is 
introduced, which is analogous to n̅̅̅̅  and is defined as the concentration of metal bound ligand 
divided by the total metal concentration. For a 1:1 metal to ligand complex θ  is given by 
Equation 35 (where Ln- is either 2SAC3- or 2SGT4- and Ks is either K2SAC-Cu or K2SGT-Cu). 
 § = [ − J!a ][J!a]%+ =
1[	]
1 + 1[	] 
(35) 
 § = 1([	] − §[	]) (36) 
 
By rearranging Equation 35 to obtain 
Equation 36 there should be a linear 
relationship between θ and ([Ln-]- θ[Ln-]) 
with the slope being equal to KS. Figure 35 
shows a representative graph.  
Figure 35: Slope of the above graph gives the 
binding constant between 2SAC and copper (II) 
62 
 
    
Alternating least squares multi curve resolution analysis. Spectral data from the 
titrations were loaded into a matrix in Matlab. A matrix was made of the estimated extinction 
coefficients for each absorbing component in solution. The ALS-MCR algorithm (Appendix A) 
was used to adjust extinction coefficients and concentration values to obtain the best fit for the 
experimental spectra.   
 
Determination of solution access to copper using 
19
F NMR. Solution access to copper 
in 2SAC-Cu and 2SGT-Cu was studied by methods similar to those described above for SOD 
inhibition. In this experiment the relaxation of the 19F NMR signal of 20 mM fluoride by 1 μM 
copper (II) was monitored as a function of added ligand. The experiments for 2SAC-Cu and 
2SGT-Cu were both conducted at pH 5 using an acetate acid buffer prepaid as described above.  
 
2SAC-Cu superoxide redox cycling. The effect of superoxide on the steady state ratio 
of Cu2+ to Cu+ was determined by measuring the effects of the superoxide generating compounds 
NADH/PMS on the 19F NMR relaxation rate of the fluoride ion. A concentrated sample of 
Cu(NO3)2 was added to a pH 5.0 NMR buffer (preparation described above) until the 
19F NMR 
relaxation rate was around 100 s-1. Aliquots of NADH and PMS solutions were added to 500 μL 
samples of buffer/Cu solution. The final concentrations of NADH and PMS were 78 and 3.3 μM 
respectively. The added NADH and PMS solutions had a negligible effect on the total volume. 
The time after the PMS addition was monitored using a stopwatch. The relaxation rate (R2) of the 
19F resonance was determined periodically using the CPMG experiment (described earlier) until a 
stabile value was obtained. For the 2SAC-Cu data the procedure was repeated using 500 μL of 
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the same stock buffer/Cu solution except 2SAC was added from a concentrated solution to give 1 
mM 2SAC with negligible change in volume. 
 
2SAC-Cu/2SGT-Cu cyclic voltammetry. Cyclic voltammograms were recorded using a 
2 mm2 gold working electrode and Ag/AgCl reference electrode. Ionic strength maintained at 0.1 
with acetate buffer. A scan rate of 50 mV/s was used for all voltammograms. The pH was 
maintained at pH 5 with a 0.1 M acetate buffer. 
 
2SAC-Cu/2SGT-Cu hydroxyl radical formation. H2O2 was added to a solution 
containing 2 mM of 2SAC or 2SGT, 0.2 mM Cu2+, 20 μM rhodamine B, and 0.1 M acetate 
solution at pH 5. The final concentration of H2O2 was 3.5%. The rhodamine B absorbance at 555 
nM was recorded over the course of approximately 20 minutes.  
 
 
Application of Methods to Study Metal Ion Participation in Complication of Diabetes 
Results and Discussion 
 
 
2SAC and 2SGT acid dissociation constants.  From the titration data we were able to 
determine three protonation constants for 2SAC and five were found for 2SGT. The pKa (-
log(1/KH)) values corresponding to these protonation constant are given in Table 5.  The three 
pKa values found for 2SAC most likely arise due to deprotonation of the three carboxylic acids. 
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For 2SGT, the first four pKa values are thought to correspond to the four carboxylic acids while 
the fifth pKa is thought to correspond to the amine. These assignments are consistent with known 
pKa values for carboxylic acids and amines (typically found between 2 and 5, and between 9 and 
10 respectively).34 
 
 
2SAC-Cu stability constant. Titrations of 2SAC in the presence and absence of copper 
(II) allowed the determination of the 2SAC-Cu stability constants. The stability constant for the 
2SAC copper (II) complex was found to be 
log(KCu(II)-2SAC) = 3.59 ± 0.05 (results given in 
Table 6). This value makes the stability constant 
for 2SAC-Cu an order of magnitude larger than 
the stability constant for the corresponding 
complex of succinic acid ( log(Ks) = 2.6).
25 This increased stability reflects an increased negative 
charge on the ligand and suggests that 2SAC may coordinate to the copper by more than just the 
succinic acid moiety. 
 
Species pKa1 pKa2 pKa3 pKa4 pKa5 
2SAC 2.57 ± 0.06 3.48 ± 0.03 4.6 ± 0.2 - - 
2SGT 2.43 ± 0.07 3.13 ± 0.02 3.83 ±0.03 4.898 ± 0.001 10.25 ± 0.09 
Table 5: pKa values for 2SAC and 2SGT found from titrations with NaOH 
complex logKs  I = 0.1 M 
Cu(II)-2SAC   3.59 ± 0.05a 
Cu(II)-2SGT   10.9 ± 0.2b 
 Table 6. Metal binding constant for 
2SAC and 2SGT 
a)KNO3 salt b) KCl salt 
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2SGT-Cu stability constant. The spectral data indicates that more than one metal/ligand 
species was present over the course of the 2SGT-Cu(II) titrations. As shown in Figure 36, the 
spectra for 2SGT-Cu(II) titrations did not display isosbestic behavior. Panel B shows normalized 
absorbance (to the maximum for each wavelength) at 350 and 600 nm (red triangles and blue 
squares respectively) over laid on the pH data from the titration. The absorbances at these two 
wavelengths increase with added base until the first five equivalences of NaOH were added. If 
there were only one species, the absorbance would either continue to increase or level off at this 
point. Instead, we observed a decrease in the absorbance from this equivalence point indicating at 
least a one additional species is formed.  
 (2SGT − Cu)	 ⇌  (2SGT − Cu)	 +  2H (37) 
 
  The pH data obtained from titrations of 2SGT and copper (II) (Figure 37), displayed 
inflections at 5 and 7 equivalents of NaOH, indicating shows that 2SGT has two additional acidic 
protons in the presence of copper (II) than in its absence. We attribute this behavior to 
coordination of copper by two peptide amide nitrogens. This is consistent with a crystal structure 
  
A)          B) 
Figure 36: A) UV/Vis spectra for 2SGT-Cu(II) titration. B) Selected normalized absorbance at 
selected wavelengths overlaid on experimental pH data for a 2SGT-Cu(II) titration. 
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that showed glutathione binds copper 
via two amide nitrogens when crystals 
were obtained at pH 11.33 It is likely 
2SGT binds copper in a similar manner 
under alkaline conditions. If this is 
occurring, then the equilibrium for the 
second species is given in Equation 37. 
At lower pH the complex involves the 
deprotonated carboxylic acid and amine 
groups ((2SGT-Cu(II))2-, Equation 30). 
The amide bound 2SGT-Cu(II) species ((2SGT-Cu(II))4-) is only likely to be of 
physiological importance since it is formed at high pH.  The binding constant for the (2SGT-
Cu(II))2- complex was established using the method described above for 2SAC-Cu(II).  Only data 
from samples with a pH less than 6.5 was 
used in the calculation to ensure that 
(2SGT-Cu(II))4- had a negligible 
influence. Figure 38 shows the 
distribution of species determined from 
this calculation overlaid on the pH data. 
The binding constant was determined to 
be log(K2SGT-Cu(II)) = 10.9 ± 0.2 from this 
distribution of species. 
 
 
Figure 37: Experimental titration of 2SGT with 
copper shows equivalence points at 5 and 7 
equivalences of NaOH. 
 
Figure 38: Fraction of each species calculated for 
titrations of 2SGT-Cu overlaid on the 
experimental pH data. 
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Electrochemistry of the 2SAC and 2SGT copper complexes. The electrochemistries of 
2SAC-Cu and 2SGT-Cu were studied by cyclic voltammetry. Figure 39A shows the 
voltammogram for copper in an acetate buffer (pH 5) without added ligand. There are two 
cathodic and two anodic peaks. We attribute these peaks to the reduction of copper (II) to copper 
(I) then to copper metal in two discrete steps. The reverse sweep shows the oxidation of copper 
metal to copper (I) then to copper (II) again in two discrete steps. Because we are interest in the 
interactions of 2SAC with copper (II) and copper (I), voltammograms were limited to a potential 
range of 400 to -50 mV range to prevent the 
deposition of copper metal. Figure 39B shows 
voltammograms in this potential range for different 
ratios of Cu(II) to 2SAC. The similarity of the 
voltammograms indicates that there are no 
significant differences between the redox activities 
of the Cu-2SAC complex and free copper (discussed 
below). Since the reduction potential for the Cu(II) 
to Cu(I) is 153 mV, and within the range specified 
 
Figure 39: A) CV data for copper. B) CV data for different ratios of Cu(II) to 2SAC. 
Conditions for A and B were 2 mm2 gold working electrode, Ag/AgCl reference electrode, v 
= 50 mV/s, acetate buffer pH 5, and ionic strength of 0.1 M (acetate buffer)  
Figure 40. Hesse’s Law diagram for 
the reaction of 2SAC with Cu(II) and 
Cu(I) 
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by Boukhalfa et al., thermodynamically the 2SAC-Cu complex should be able to catalyze the 
Haber-Weiss Cycle (Equations 1-4). We have confirmed this prediction experimentally 
(discussed later).34,29  
The similarity of the voltammograms in the presence and absence of 2SAC also indicates 
that the stability constants for the copper (II) and copper (I) complexes of 2SAC are similar. This 
is illustrated by considering the reaction diagram shown in Figure 40. Hess’s law requires that 
ΔG4 is related to ∆G1 according to Equation 38.  Since the voltammograms were not affected by 
addition of 2SAC, ΔG2 must be similar to ΔG3 and ΔG4 must be similar to ΔG1 (Equations 38-
40). 
 ∆G	 	− ∆G + ∆G + ∆G (38) 
 ∆G = −nFE (39) 
 ∆G = −RT lnK (40) 
 The voltammograms recorded for solutions containing 2SGT and copper (II) are shown 
in Figure 41. These voltammograms were run over the larger potential range then for 2SAC 
because the cathodic peak 
observed at approximately 
10 mV in the 2SAC and 
copper voltammograms was 
not as pronounced in the 
2SGT and copper 
voltammograms. As shown 
in Figure 41, 
voltammograms of solutions 
containing 2SGT and 
 
Figure 41: CV data for different ratios of 2SGT and Cu(II). 
Conditions were 2 mm2 gold working electrode, Ag/AgCl 
reference electrode, v = 50 mV/s, acetate buffer pH 5, and 
ionic strength of 0.1 M (acetate buffer)  at pH 5. 
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copper (II) show a cathodic peak decreasing in intensity with added 2SGT. Also, there are two 
anodic peaks shown in the pure copper (II) sample. With the addition of 2SGT the anodic peaks 
shift to more negative potentials with the peak initially at c.a. 190 mV almost disappearing in the 
1:1 sample. We believe the difference between the voltammograms in the two experiments is due 
to kinetic effects which may have been due to different surface preparation of the electrodes. 
Since addition of the ligands to copper show mostly kinetic effects in the voltammograms, rather 
than significant changes in the redox potential, effort was not put into reconciling the differences 
between the two experiments. 
2SAC-Cu and 2SGT-Cu metal access determined by 
19
F NMR. Metal access in 
copper complexes of 2SAC and 2SGt were studied by 19F NMR. As shown in figure 42A, the 
NMR relaxation activity of 1 μM copper (II) decreases with increasing concentration of 2SAC. 
However, even with three orders of magnitude higher concentration 2SAC than copper (II) there 
still remains around 10 % activity. This result indicates that the 2SAC-Cu(II) species must also 
contribute to the relaxation of the fluoride.  
  
Figure 42: A) Relaxation of the fluoride NMR signal as a function of 2SAC concentration. 
B) Relaxation rate of the fluoride signal for bound and unbound copper (II). 
A 
B 
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A separate experiment was run to determine the extent to which 2SAC-Cu(II) species 
contributes to 19F relaxation. In this experiment the concentration of 2SAC was held constant at 
10 mM and the concentration of copper (II) was varied from 1 μM to 3 μM (Figure 42B). The 
concentration of unbound copper was calculated using the binding constant for 2SAC and copper 
(II). The contribution of unbound copper (II) to the relaxation rate is shown in Figure 42B as 
green triangles. The difference between the observed relaxation rate (blue diamonds) and that due 
to free copper (shown as red squares in Figure 42B) is due to the relaxation of the fluoride by the 
2SAC-Cu(II) species. Using the calculated concentrations of the free copper (II) and the know 
relaxation rate of free copper (c.a. 2.5	X	108	R2/M) the molar relaxation rate of 2SAC-Cu(II) was 
found to be 2.0	X	107	R2/M.  
Since the 2SAC-Cu(II) species causes relaxation of the fluoride, we conclude that 
fluoride ions must be able to access  the bound copper. By analogy, other small molecules such as 
the superoxide ion and H2O2 should be able to access the copper ion in the 2SAC-Cu complex.  
The affets of 2SGT on the 19F NMR 
relaxation enhancement of copper (II) is shown in 
Figure 43. This experiment shows that upon addition 
of the 2SGT, NMR relaxation the activity of the 
copper drops to essential zero very quickly (60 μM 
and higher 2SGT with 2 μM Cu(II) gives less than 10 
% activity). This result indicates that the 2SGT 
ligand wraps around the copper (II) ion, preventing 
access to the fluoride ion. By analogy, other small molecules such as superoxide or H2O2 would 
also not be able to contact the copper in the 2SGT-Cu complex.  
 
 
Figure 43. Relaxation of the 
fluoride signal as a function of 
2SGT concentration. 
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Reactions of superoxide with 2SAC-
Cu. Using the 19F assay described earlier, we 
were able to determine that 2SAC-Cu is 
reduced to copper (I) by superoxide but is not 
re-oxidize. Thus 2SAC-Cu will not catalyze 
the disproportionation of superoxide. In this 
experiment we used NADH/PMS to generate 
superoxide and monitored its effect on 19F 
relaxation by either free copper (II) or 2SAC-
Cu(II). As described earlier, redox cycling would result in a steady state concentration of copper 
(II) which would be detected from its relaxation activity. Figure 44 shows that upon addition of 
NADH/PMS relaxation rate drops to essentially zero, indicating the copper (initial in its +2 
oxidation state) is reduced to copper (I), for both the control and sample with 2SAC.  
 
Hydroxyl radical formation. We investigated the ability of 2SAC-Cu and 2SGT-Cu to 
catalyze hydroxyl radical formation from 
H2O2. These experiments show that 2SAC-
Cu will catalyze the formation of the 
hydroxyl radical from H2O2 while the 2SGT-
Cu compound will not. 
 The formation of hydroxyl radicals 
was investigated by monitoring the 555 nm 
absorbance of rhodamine B. It has been 
demonstrated that reactions with hydroxyl 
 
Figure 44. Upon addition of superoxide 
generating reagents the copper (II) is 
reduced to copper (I) and is not re-oxidized. 
 
 
Figure 45. rhodamine B absorption at 555 nm. 
In the presence of hydroxyl radical producing 
species the absorbance of rhodamine B 
decreases. 
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radicals bleaches the 555 nm absorbance of rhodamine B.35 Figure 45 shows the experimental 
data from solutions containing 2SAC-Cu(II), 2SGT-Cu(II), and a control sample. Upon addition 
of H2O2 the rhodamine B absorbance at 555 nm decreases in the sample containing 2SAC-Cu(II) 
but not in the samples containing 2SGT-Cu. It has been reported that certain metal complexes 
catalyze the disproportionation of 2H2O2 to 2H2O and O2 via a radical mechanism.
37 Our results 
suggest that 2SAC-Cu catalyzes the disproportionation of H2O2 via a radical mechanism as 
describe by Equations 41 and 42.  In the case of 2SGT-Cu, no significant change in the 
rhodamine B absorption at 555 nm was observed. This result indicates that 2SGT-Cu does not 
catalyze the formation of the hydroxyl radical. This result combined with the 19F result suggests 
that metal accessibility is necessary for catalytic reactions that form the hydroxyl radical. 
 2d² +  → 2d² + + 2 (41) 
 d² +  → d² + 	 + . (42) 
 
  
  
Application of Methods to Study Metal Ion Participation in Complication of Diabetes 
Conclusion 
 
 
We have synthesized the compounds 2SAC and 2SGT and have determined their copper 
(II) binding constants. Using 19F NMR assays, we have shown that the metal in 2SAC-Cu is 
accessible to small atoms/molecules while the metal in 2SGT-Cu is not. This accessibility allows 
2SAC-Cu to catalyze further reactions involving small molecules. We demonstrated that 2SAC-
Cu(II) reacts with superoxide to give the corresponding copper (I) complex. We have also shown 
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that 2SAC-Cu(I) reacts with H2O2 to give the hydroxyl radical. Since the Haber-Weiss reaction is 
the sum of these reactions, these experiments indicate that 2SAC-Cu will catalyze the Haber-
Weiss reaction. The inaccessibility of the metal in the 2SGT-Cu species appears to prevent metal 
catalyzed reactions involving superoxide and H2O2. These results suggest that the 2SC-Cu 
complexes in vivo might catalyze the Haber-Weiss reaction depending on whether other 
coordinating groups are present in the specific ligand. 
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APPENDIX A 
(Matlab Code) 
 
 
Alternating Least Squares Multi Curve Resolution 
%this is the als engine to interatively refine guesses in C or K matrix 
% currently this function only works with Ki guesses 
% 
%usage:  [K, C] = alsKgf(A,Ki,options,tolerance) 
% notes: 
% all spectra are row vectors 
% options is a column vector of flags 
% $$$  options = [1;%non negativity in C 
% $$$             1;%non negativeity in K 
% $$$             1;% closer in C 
% $$$             1;% unassigned 
% $$$             1;% unassigned 
% $$$             1;% unassigned 
% $$$             1;% unassigned 
% $$$             1];% unassigned 
             
            
function [K, C] = alsKgf(A,Ki,options,tolerance) 
Ki = mkrow(Ki); 
[npc, npts] = size(Ki); 
[nspec, npts] = size(A); 
  
C = zeros(nspec,npc); 
K = Ki; 
%begin convergence test loop 
decide = 10000000; 
RSDold = 10000000; 
while abs(decide) > tolerance 
  
 C = A*K'*inv(K*K'); 
 %closer constraint for C 
 if (options(3) == 1) 
   for i = 1:nspec 
     C(i,:) = ccr(C(i,:),1)'; 
   end 
 end 
 %non negative constraint in C 
 if (options(1) == 1) 
   for i = 1:npc 
     C(:,i) = cnn(C(:,i))'; 
   end 
 end 
 K = inv(C'*C)*C'*A; 
 %non negative constraint in K 
  if (options(2) == 1) 
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   for i = 1:npc 
     K(i,:) = cnn(K(i,:))'; 
   end 
 end 
 Ag = C*K; 
 RSD = sum(sqrt((sum(A-Ag).^2)/(nspec-2))); 
 decide = (RSD-RSDold)*100; 
 disp([num2str(abs(decide(1,1))) ' must be less than ' 
num2str(tolerance)]) 
 RSDold = RSD;   %see Anal. Chem. vol 72 no 9 1956-1963  
End 
 
 
Non-Negativity Constraint 
%this function will apply the non-negativity constraint to a row vector 
%usage: rowvecout = cnn(rowvecin) 
  
function out = cnn(v) 
v = mkrow(v); 
[nr,nc] = size(v); 
out = v; 
for i = 1:nc 
  if v(1,i) < 0.0001 
    out(1,i) = 0.00000;   
  end 
end 
return 
 
 
Closer Constraint (Normalize Concentration or Spectra to Approximately 1) 
%this function will apply the closer constaint to a row vector 
%usage: rowvecout = ccr(rowvecin, Formal_concentration) 
%  
function out = ccr(v,conc) 
v = mkrow(v); 
[nr,nc] = size(v); 
out = v; 
  
scale = sum(v(1,:))/conc; 
if (sum(v(1,:)) ~= 1) 
  out(1,:) = v(1,:)/scale;    
end 
  
return 
 
 
Principal Component Analysis Using Percent Error 
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%This function will produce the percent error for different PC of a   
%spectral matrix A using svd 
% A(nspec,npts) = scores(nspec,nlv)loadvec(nlv,npts) 
% usage:  [stdv] = svdpcastdv(A,nlv) 
function [pct] = svdpcapct(A,nlv) 
[nspec, npts] = size(A); 
[U,S,V] = svd(A); 
  
for a = 1:nlv; 
loadvec = V(1:npts,1:a); 
s = A*inv(V'); 
scores = -1*s(1:nspec,1:a); 
loadvec = -1*loadvec'; 
err=(A-(scores*loadvec)); 
pct(a,1)=1-(sum(sum(abs(err))))/(sum(sum(abs(A)))); 
  
end 
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APPENDIX B 
(2SAC AND 2SGT SPECTRA) 
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Figure 46: 2SAC 1H NMR Spectrum 
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Figure 47: 2SAC 1H NMR Spectrum zoom 1 
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Figure 48: 2SAC 13C NMR Spectrum 
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Figure 49: 2SAC 13C NMR Spectrum (zoom 1) 
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Figure 50: 2SAC 13C NMR Spectrum (zoom 2) 
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Figure 51: 2SAC COSY Spectrum 
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Figure 52: 2SAC COSY Spectrum (Zoom 1) 
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Figure 53: 2SAC HSQC Spectrum 
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Figure 54: 2SAC HSQC Spectrum (zoom) 
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Figure 55: 2SAC HMBC Spectrum  
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Figure 56: 2SAC HMBC Spectrum (zoom 1) 
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Figure 57: 2SAC HMBC Spectrum (zoom 2) 
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Figure 58: 2SAC ESI Mass Spectrum. Positive ion mode, tuned to m/z = 280, 50 µL/min flow 
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Figure 59: 2SGT 1H NMR Spectrum 
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Figure 60: 2SGT 13C Spectrum 
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Figure 61: 2SGT 13C Spectrum (Zoom 1) 
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Figure 62: 2SGT 13C Spectrum (Zoom 2) 
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Figure 63: 2SGT COSY Spectrum 
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Figure 64: 2SGT COSY Spectrum (Zoom 1) 
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Figure 65: 2SGT HSQC Spectrum 
 
 
101 
 
 
Figure 66: 2SGT HSQC Spectrum (Zoom 1) 
 
 
102 
 
 
Figure 67: 2SGT HMBC Spectrum 
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Figure 68: 2SGT HMBC Spectrum (Zoom 1) 
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Figure 69: 2SGT HMBC Spectrum (Zoom 2) 
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Figure 70: 2SGT ESI Mass Spectrum. Positive ion mode, tuned to m/z = 424, 10 µL/min flow 
rate 
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APPENDIX C 
(TITRATION SETUP – HARDWARE) 
 
 Shown below is a typical setup for titrations. This setup allow for recording of the pH and 
UV/Vis spectra while titrating in a solution in an anaerobic. The setup includes a three neck flask 
sealed with rubber septa, a syringe pump for injection of the titrant; a peristaltic pump connected 
to a flow cell to record UV/Vis spectra, a pH meter sealed with a rubber o-ring and screw cap, 
and a vacuum hose connected to a Schlenk line to maintain an inert environment (shown below).  
 
 
 A closer view of the three neck flask is shown below. Syringe needles are used to inject 
the titrant from the syringe pump, as well as going to and from the peristaltic pump/flow cell. The 
 
Figure 71: Titration hardware setup. 
Syringe pump 
with syringe 
pH probe 
Peristaltic 
pump 
Cuvette holder 
with flow cell 
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pH electrode is connected to a glass adapter with a rubber o-ring and screw cap. The Schlenk line 
is also connected to a gas hose fitting on the glass adapter (shown below). 
 
 
 
 
 
 
 
 
 
  
 
Figure 72: Three neck flask setup for titrations.  
Vacuum hose to 
Schlenk line 
Glass adapter 
Syringe needle 
to peristaltic 
pump/flow cell 
Syringe 
needle from 
peristaltic 
pump/flow 
Syringe needle 
from syringe pump 
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APPENDIX D 
(TITRATION SOFTWEAR SETUP) 
 
To run a one of the titrations described in this thesis usually three programs were used: 
SyringePumpPro, HI92000 (pH meter), and BWSpec (UV/Vis spectrometer). This appendix 
describes the basic use of these programs and how they are coordinated to run a titration.  
 
Syringepumppro 
The first program to be described is the SyringPumpPro. This program requires that first a 
pumping program be created using the supplied Excel template (indicated below with a red 
arrow). 
 
 Once opened the pump program creator is somewhat self explanatory. The Excel 
template has two sheets. The first is shown below and is where the details of the pumping 
program are entered. It should be noted that the maximum time a pause function can last is 99 
seconds also the maximum number of loops in one loop function is 99. If more time or loops are 
need then multiple loops must be set up.  
 
 
Figure 73: Pump program creator Excel sheet. 
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The details of the pumping program created on sheet one are automatically copied to sheet two 
(shown below). Instructions on how to save the pump program are given at the top of the second 
sheet. Each pumping program should be saved as a *.PPL file. 
 
Figure 74: Pump program creator sheet 1. 
Set pumping 
program details here. 
Set the syringe type 
and size as well as 
volume units. 
 
Figure 75: Second sheet of the pump program creator 
excel template. 
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Once the pumping program is saved then open the SyringPumpPro program (indicated below 
by the red arrow).  
 
 Once open the SyringPumpPro program should look like the screen shot shown below. At 
the top of the screen the program should say “2 pumps licensed” and “Pump 00” should be 
displayed in the white box on the top half of the screen.  
 
 
 
 
 
 
 
 
 
If the “2 pumps licensed” is not displayed then you probably need to log off and have an 
administrator log on (Dr. Summers). If no pump is displayed in the white box in the top half of 
 
Figure 76: Pump program creator Excel sheet. 
 
Figure 77: SyringPumpProg program. 
Should say  “2 
pumps licensed” 
Should shown 
“Pump 00” here 
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the screen then go to the Pump Network tab and click on the Auto Detect Pump Network (red 
arrow below). It should take about 5 seconds before it finds the pump 
 
 
 
 
 
 
 
 
 
 
  
Once the pump is ready to go, right click on Pump 00 in the white box in the top half of the 
screen. In the pop up text box, click on the Program/PPL File (as show below) to upload the 
pump program. 
Figure 78: Select “Auto Detect Pump Network” if now pumps are 
shown. 
 
Figure 79: Select “Program/PPL File” to upload a pump 
program. 
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 Once the pumping program is uploaded you can simply run the program by clicking 
“Run” on the right hand side of the screen. However if you want to record the pH and/or UV/Vis 
spectra you should wait to coordinate the timing of each program.  
 
HI92000 (pH Meter)  
To set up the pH meter to record the pH over the course of a titration fist click on the HI9200 icon 
(red arrow in panel A in the figure below). There will be a pop up window as shown in panel B in 
the figure to the below. Click on the “Real Time Logging” option. 
 
Once open the screen looks as shown below. To adjust the communications port, baud rate, and 
time interval at which the pH data is taken go to the Setup tab as indicated by the red arrow 
below. 
 
 
Figure 80: A) pH meter desktop icon. B) Select “Real Time Logging” 
for titrations.  
A B 
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 The Setup screen for the pH meter is shown below. There are two areas of this screen that should 
be adjusted: the Communications area and the Auto Log area. For the Communications area, first 
of all make sure the communications port is correct. If you’re not sure you can click on the 
“Detect Selected Instrument” button and the software will find the correct port. Next make sure 
the Baud rate is set to 9600.  
 
For the Auto Log area there are two options that must be adjusted. Fist the Sample delay, 
which is the amount of time between each pH reading. Second is the Maximum sample number, 
 
Figure 82: Setup screen for HI92000 software.  
 
Figure 81: Select the “Setup” tab to adjust 
the communications port, baud rate, and time 
interval. 
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which is the total amount of data points that will be taken. It should be noted that there is a time 
zero reading which should be taken into account when setting the maximum sample number. 
These options will need to be set to suit each titration. 
Once the settings are correct hit Ok, this will bring you back to the main screen. Once ready 
click the Connect button (shown in figure A below). This will connect the software to the pH 
meter. Once connected the Auto Log button will be available (shown in figure B below). Click 
the Auto Log button when ready to start collecting data. This will start reading the pH (at time 
zero) at the selected time interval and for the selected number of data points.  
115 
 
 
 
 
 
 
Figure 83: A) Select “Connect” once the settings in the “Setup” tab are adjusted. 
B) Select “Auto Log” to start logging data. 
A 
B 
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BWSPEC (UV/VIS Spectrometer) 
 To open the UV/Vis spectrometer click on the BWSpec icon shown below.  
 
Once opened the UV/Vis spectrometer looks as shown below. Befor taking a single spectra or a 
series of spectra for a titration there are two controls that must be set. The fist is a Dark scan and 
the second is a Reference scan. To set these controls use the buttons at the top-center of the 
screen. For the dark scan the shutter should be closed on the light source. Then simply click the 
dark scan button (Figure 85). Once the Dark scan is taken, open the shutter on the light source 
 
Figure 84: Desktop icon for the 
BWSPEC spectrometer. 
 
Figure 85: Software screen for the BWSpec spectrometer. 
Dark scan Reference scan 
Dark and Reference 
scan indicators 
Acquire overlay 
Acquire one spectrum 
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and place a cuvette with a reference solution in the cuvette holder. Then click the Reference scan 
button (Figure 85). At the bottom right hand of the BWSpec screen there is two indicators to let 
you know that the Dark and reference scans have been taken.  
 Once the Dark and Reference scans have been taken you can take a single scan by 
clicking on the Acquire One Spectrum button (shown above), take an overlaid spectrum by 
clicking the Acquire Overlay button (shown above), or take a spectrum at a set time interval. The 
third option is what will be used for titrations.  
To set-up the spectrometer to acquire data for a titration go to the Acquire tab at the top 
right of the screen. Under the Acquire tap click on the Timeline… option (shown below).  
 
 
Figure 86: Select “Timeline” from the “Acquire” tab for to take spectra at 
a selected time interval. 
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 Initially the Timeline window looks as shown below. Click on the green down arrow 
(shown below) to show more options.  
 
After clicking on the green down arrow, the Timeline window looks as shown below. There are 
four things to that should be set in this window: the Save Path, the Total #, Internal Pacer, and the 
Output Timeline Data to Spreadsheet check box. The Save Path is simple the location which the 
spectra will be saved, the Total # is the total number of spectra that will be taken (including a 
time zero spectrum), the Internal Pacer is the time interval between each spectrum taken, and the 
Output Timeline Data to Spreadsheet check box will export the spectra to an Excel sheet once all 
 
Figure 88: Settings to be adjusted in the “Timeline” window. 
Location spectra 
will be saved to Total # of spectra 
Export data to Excel 
Time interval 
between spectra 
Start collecting 
spectra 
 
Figure 87: Select the green down arrow for more options in the 
“Timeline” window. 
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the data is collected if checked. 
 Once the Timeline settings have been adjusted the data collection can be started by 
clicking the go button as shown above.  
 
Coordinating Titration Software 
To run the three programs together simply coordinate the start timing of each program 
using a stopwatch.  It is convenient to program a pause (30 seconds) initially in the pumping 
program to allow easier coordination of the pH meter and spectrometer.   
